Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Retrocyclins: using past as prologue.

Alexander M Cole1, Wei Wang, Alan J Waring

  • 1Department of Molecular Biology, Biomolecular Science Center, University of Central Florida, Orlando, FL 32816-2364, USA.

Current Protein & Peptide Science
|November 17, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nasal microbiome inhabitants with anti-<i>Staphylococcus aureus</i> activity.

Microbiology spectrum·2025
Same author

What is new in synthetic lung surfactant protein technology?

Expert review of respiratory medicine·2024
Same author

Moving on from clinical animal-derived surfactants to peptide-based synthetic pulmonary surfactant.

American journal of physiology. Lung cellular and molecular physiology·2024
Same author

Structure and Function of Canine SP-C Mimic Proteins in Synthetic Surfactant Lipid Dispersions.

Biomedicines·2024
Same author

Characterization of erythroferrone structural domains relevant to its iron-regulatory function.

The Journal of biological chemistry·2023
Same author

Lung Surfactant Protein B Peptide Mimics Interact with the Human ACE2 Receptor.

International journal of molecular sciences·2023

Synthetic retrocyclins, derived from ancient primate genes, show promise as antiviral agents. These molecules effectively block viral entry by binding to carbohydrates on cell surfaces, offering potential for new drug development.

Area of Science:

  • Biochemistry
  • Evolutionary Biology
  • Virology

Background:

  • Theta-defensins are synthetic peptides reconstructed from ancient primate genetic blueprints.
  • While some nonhuman primates produce Theta-defensins, humans and great apes possess defective genes.
  • This genetic defect, a premature stop codon, prevents the natural production of these peptides in humans.

Purpose of the Study:

  • To investigate the antiviral properties of synthetic retrocyclins.
  • To explore the mechanism by which retrocyclins inhibit viral entry.
  • To assess the potential of retrocyclins as prototypes for novel antiviral agents.

Main Methods:

  • Phylogenetic analysis to trace the evolutionary origin of Theta-defensins.
  • In vitro studies to evaluate the ability of retrocyclins to prevent viral entry (e.g., HIV-1, HSV-2).

Related Experiment Videos

  • Biochemical assays to determine the interaction of retrocyclins with carbohydrate epitopes on viral and cellular glycoproteins.

    • Main Results:

    • Synthetic retrocyclins demonstrated efficacy in preventing the entry of HIV-1 and HSV-2 into human cells.
    • The antiviral activity is linked to the ability of retrocyclins to bind carbohydrate moieties on viral and cell-surface glycoproteins.
    • Retrocyclins exhibit lectin-like activity, identifying them as the smallest known natural sugar-binding molecules.

    Conclusions:

    • Synthetic retrocyclins, derived from ancient Theta-defensin genes, possess significant antiviral properties.
    • Their carbohydrate-binding ability is key to inhibiting viral entry, suggesting a novel mechanism of action.
    • Theta-defensins represent promising molecular prototypes for the development of new carbohydrate-binding and antiviral therapeutics.